Società Bacterin International Holdings Inc Nyse
Azioni
BONE
US05644R2004
Fornitura medica
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Orthobiologics
64,2
%
| 47 | 81,3 % | 59 | 64,2 % | +24,31% |
Spinal Implant
35,8
%
| 11 | 18,7 % | 33 | 35,8 % | +202,34% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
94,0
%
| 57 | 98,6 % | 86 | 94,0 % | +50,21% |
Rest of World
6,0
%
| 1 | 1,4 % | 5 | 6,0 % | +574,23% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sean Browne
CEO | Chief Executive Officer | 58 | 07/10/19 |
Scott Neils
DFI | Director of Finance/CFO | 40 | 01/08/19 |
Chief Operating Officer | - | 16/01/23 | |
Kevin Brandt
PRN | Corporate Officer/Principal | 59 | 09/07/18 |
Stephen C. Smith
LAW | General Counsel | - | 01/02/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 58 | 16/05/23 | |
John Bakewell
BRD | Director/Board Member | 62 | 01/02/18 |
Robert McNamara
BRD | Director/Board Member | 67 | 01/02/18 |
Sean Browne
CEO | Chief Executive Officer | 58 | 07/10/19 |
Jonn Beeson
BRD | Director/Board Member | 55 | 01/05/23 |
Chairman | 53 | 23/08/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 130 268 590 | 120 704 263 ( 92,66 %) | 0 | 92,66 % |
Coordinate società
![Indirizzo Bacterin International Holdings Inc(BONE)](https://cdn.zonebourse.com/static/address/17067786.png)
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+13,23% | 129 Mrd | |
-8,84% | 10,82 Mrd | |
-16,57% | 7,12 Mrd | |
+43,02% | 5,66 Mrd | |
-30,97% | 4,14 Mrd | |
+8,63% | 3,46 Mrd | |
-19,74% | 2,47 Mrd | |
-17,06% | 1,95 Mrd | |
-22,28% | 1,7 Mrd |